Literature DB >> 23750873

Management strategies and medication use for treating paediatric patients with concussions.

Karen A Kinnaman1, Rebekah C Mannix, R Dawn Comstock, William P Meehan.   

Abstract

AIM: To assess management strategies for paediatric patients suffering from concussions.
METHODS: A 17-item questionnaire was distributed to 1305 section members of the American Academy of Pediatrics Sections on Adolescent Health, Sports Medicine and Fitness, Community Pediatrics and School Health. The use of medications, neuropsychological testing, neuroimaging and published guidelines in concussion management was queried.
RESULTS: Two hundred and twenty respondents (17%) completed the questionnaire, of which 64% had been an attending for greater than 10 years. A majority of respondents (92%) managed patients with concussions, with 26% treating more than 24 patients per year. Most paediatricians (84%) reported using a published guideline. The majority of respondents (89%) manage the symptoms of concussed patients with medications, most commonly acetaminophen (62%) or nonsteroidal anti-inflammatory medications (54%). The use of prescriptions medications such as tricyclic antidepressants (23%), amantadine (10%) and methylphenidate (8%) was also commonly reported. Paediatricians treating >16 patients per year with concussion were more likely to prescribe tricyclic antidepressants, stimulants and agents used for sleep disturbance.
CONCLUSION: Paediatricians nationwide routinely use medications when managing patients with concussions. The pharmacological agents used differ according to number of patients treated per year. In addition, most paediatricians use published guidelines in concussion management. ©2013 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Concussion; Medication management; Paediatric patient

Mesh:

Substances:

Year:  2013        PMID: 23750873     DOI: 10.1111/apa.12315

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Factors associated with delayed recovery in athletes with concussion treated at a pediatric neurology concussion clinic.

Authors:  Suzanne Bock; Rod Grim; Todd F Barron; Andrew Wagenheim; Yaowen Eliot Hu; Matthew Hendell; John Deitch; Ellen Deibert
Journal:  Childs Nerv Syst       Date:  2015-08-05       Impact factor: 1.475

Review 2.  Current and emerging rehabilitation for concussion: a review of the evidence.

Authors:  Steven P Broglio; Michael W Collins; Richelle M Williams; Anne Mucha; Anthony P Kontos
Journal:  Clin Sports Med       Date:  2015-01-24       Impact factor: 2.182

Review 3.  Psychiatric Sequelae of Concussions.

Authors:  David A Brent; Jeffrey Max
Journal:  Curr Psychiatry Rep       Date:  2017-11-17       Impact factor: 5.285

4.  Test-Retest Reliability of Computerized Neurocognitive Testing in Youth Ice Hockey Players.

Authors:  Melissa N Womble; Erin Reynolds; Philip Schatz; Kishan M Shah; Anthony P Kontos
Journal:  Arch Clin Neuropsychol       Date:  2016-04-15       Impact factor: 2.813

5.  Healthcare Providers' Self-Reported Pediatric Mild Traumatic Brain Injury Diagnosis, Prognosis, and Management Practices: Findings From the 2019 DocStyles Survey.

Authors:  Kelly Sarmiento; Jill Daugherty; Juliet Haarbauer-Krupa
Journal:  J Head Trauma Rehabil       Date:  2021 Jul-Aug 01       Impact factor: 3.117

6.  Protracted recovery from a concussion: a focus on gender and treatment interventions in an adolescent population.

Authors:  Regina O Kostyun; Imran Hafeez
Journal:  Sports Health       Date:  2015-01       Impact factor: 3.843

Review 7.  Pharmacotherapy for Treatment of Cognitive and Neuropsychiatric Symptoms After mTBI.

Authors:  Amanda R Rabinowitz; Thomas K Watanabe
Journal:  J Head Trauma Rehabil       Date:  2020 Jan/Feb       Impact factor: 3.117

Review 8.  Pharmacologic Therapies for Pediatric Concussions.

Authors:  Mark E Halstead
Journal:  Sports Health       Date:  2016 Jan-Feb       Impact factor: 3.843

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.